National Research (NASDAQ:NRC) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

National Research Corporation (NASDAQ:NRC)’s share price passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $17.91 and traded as high as $22.65. National Research shares last traded at $22.34, with a volume of 136,814 shares trading hands.

Analyst Ratings Changes

NRC has been the subject of several research analyst reports. Weiss Ratings upgraded shares of National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 29th. Citizens Jmp assumed coverage on shares of National Research in a research report on Monday, June 22nd. They issued a “market outperform” rating and a $23.00 price target for the company. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, National Research has a consensus rating of “Moderate Buy” and an average target price of $23.00.

National Research Stock Performance

The stock has a fifty day moving average price of $19.11 and a 200-day moving average price of $17.95. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 5.48. The firm has a market cap of $509.60 million, a price-to-earnings ratio of 57.44 and a beta of 0.35.

National Research (NASDAQ:NRC) last announced its quarterly earnings data on Tuesday, April 28th. The company reported $0.21 EPS for the quarter. The company had revenue of $34.80 million during the quarter. National Research had a net margin of 6.52% and a return on equity of 122.73%.

National Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Friday, June 26th. National Research’s payout ratio is currently 164.10%.

Institutional Trading of National Research

A number of institutional investors have recently modified their holdings of the business. M&T Bank Corp boosted its stake in shares of National Research by 6.4% during the second quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock valued at $229,000 after acquiring an additional 823 shares during the last quarter. Sei Investments Co. lifted its holdings in National Research by 1.2% in the 3rd quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock valued at $975,000 after purchasing an additional 900 shares in the last quarter. Russell Investments Group Ltd. lifted its holdings in National Research by 85.6% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after purchasing an additional 921 shares in the last quarter. Invesco Ltd. boosted its stake in shares of National Research by 6.3% during the 2nd quarter. Invesco Ltd. now owns 17,368 shares of the company’s stock worth $292,000 after purchasing an additional 1,022 shares during the last quarter. Finally, Alliancebernstein L.P. grew its holdings in shares of National Research by 6.3% during the third quarter. Alliancebernstein L.P. now owns 18,499 shares of the company’s stock worth $236,000 after buying an additional 1,100 shares in the last quarter. 47.26% of the stock is currently owned by hedge funds and other institutional investors.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.